Theophylline restores histone deacetylase activity and steroid responses in COPD macrophages
Borja G Cosio, Loukia Tsaprouni, Kazuhiro Ito, Elen Jazrawi, Ian M Adcock, Peter J Barnes, Borja G Cosio, Loukia Tsaprouni, Kazuhiro Ito, Elen Jazrawi, Ian M Adcock, Peter J Barnes
Abstract
Chronic obstructive pulmonary disease (COPD) is a common chronic inflammatory disease of the lungs with little or no response to glucocorticoids and a high level of oxidative stress. Histone deacetylase (HDAC) activity is reduced in cells of cigarette smokers, and low concentrations of theophylline can increase HDAC activity. We measured the effect of theophylline on HDAC activity and inflammatory gene expression in alveolar macrophages (AM) from patients with COPD. AM from normal smokers showed a decrease in HDAC activity compared with normal control subjects, and this was further reduced in COPD patients (51% decrease, P < 0.01). COPD AMs also showed increased basal release of IL-8 and TNF-alpha, which was poorly suppressed by dexamethasone. Theophylline induced a sixfold increase in HDAC activity in COPD AM lysates and significantly enhanced dexamethasone suppression of induced IL-8 release, an effect that was blocked by the HDAC inhibitor trichostatin A. Therefore, theophylline might restore steroid responsiveness in COPD patients.
Figures
References
- Barnes, P.J. 2000. Chronic obstructive pulmonary disease. N. Engl. J. Med. 343:269–280.
- Saetta, M., G. Turato, P. Maestrelli, C.E. Mapp, and L.M. Fabbri. 2001. Cellular and structural bases of chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 163:1304–1309.
- Retamales, I., W.M. Elliott, B. Meshi, H.O. Coxson, P.D. Pare, F.C. Sciurba, R.M. Rogers, S. Hayashi, and J.C. Hogg. 2001. Amplification of inflammation in emphysema and its association with latent adenoviral infection. Am. J. Respir. Crit. Care Med. 164:469–473.
- Keatings, V.M., P.D. Collins, D.M. Scott, and P.J. Barnes. 1996. Differences in interleukin-8 and tumor necrosis factor-α in induced sputum from patients with chronic obstructive pulmonary disease or asthma. Am. J. Respir. Crit. Care Med. 153:530–534.
- Barnes, P.J. 2003. New concepts in COPD. Annu. Rev. Med. 54:113–129.
- Culpitt, S.V., D.F. Rogers, P. Shah, C. de Matos, R.E. Russell, L.E. Donnelly, and P.J. Barnes. 2003. Impaired inhibition by dexamethasone of cytokine release by alveolar macrophages from patients with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 167:24–31.
- Urnov, F.D., and A.P. Wolffe. 2001. Chromatin remodeling and transcriptional activation: the cast (in order of appearance). Oncogene. 20:2991–3006.
- Ito, K., P.J. Barnes, and I.M. Adcock. 2000. Glucocorticoid receptor recruitment of histone deacetylase 2 inhibits IL-1 β-induced histone H4 acetylation on lysines 8 and 12. Mol. Cell. Biol. 20:6891–6903.
- Barnes, P.J., K. Ito, and I.M. Adcock. 2004. A mechanism of corticosteroid resistance in COPD: inactivation of histone deacetylase. Lancet. 363:731–733.
- Ito, K., S. Lim, G. Caramori, K.F. Chung, P.J. Barnes, and I.M. Adcock. 2001. Cigarette smoking reduces histone deacetylase 2 expression, enhances cytokine expression and inhibits glucocorticoid actions in alveolar macrophages. FASEB J. 15:1100–1102.
- Barnes, P.J. 2003. Theophylline: new perspectives on an old drug. Am. J. Respir. Crit. Care Med. 167:813–818.
- Ito, K., S. Lim, G. Caramori, B. Cosio, K.F. Chung, I.M. Adcock, and P.J. Barnes. 2002. A molecular mechanism of action of theophylline: induction of histone deacetylase activity to decrease inflammatory gene expression. Proc. Natl. Acad. Sci. USA. 99:8921–8926.
- Pauwels, R.A., A.S. Buist, P.M. Calverley, C.R. Jenkins, and S.S. Hurd. 2001. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am. J. Respir. Crit. Care Med. 163:1256–1276.
- Di Stefano, A., G. Caramori, A. Capelli, M. Lusuardi, I. Gnemmi, F. Ioli, K.F. Chung, C.F. Donner, P.J. Barnes, and I.M. Adcock. 2002. Increased expression of NF-κB in bronchial biopsies from smokers and patients with COPD. Eur. Respir. J. 20:556–563.
- Tager, M., A. Piecyk, T. Kohnlein, U. Thiel, S. Ansorge, and T. Welte. 2000. Evidence of a defective thiol status of alveolar macrophages from COPD patients and smokers. Chronic obstructive pulmonary disease. Free Radic. Biol. Med. 29:1160–1165.
- Rahman, I., and W. Macnee. 1999. Lung glutathione and oxidative stress: implications in cigarette smoke-induced airway disease. Am. J. Physiol. 277:L1067–L1088.
- Ito, K., S. Watanabe, S. Kharitonov, T. Hanazawa, I.M. Adcock, and P.J. Barnes. 2001. Histone deacetylase activity and gene expression in COPD patients. Eur. Respir. J. 18:316S.
- Chalmers, G.W., K.J. Macleod, S.A. Little, L.J. Thomson, C.P. McSharry, and N.C. Thomson. 2002. Influence of cigarette smoking on inhaled corticosteroid treatment in mild asthma. Thorax. 57:226–230.
- Chaudhuri, R., E. Livingston, A.D. McMahon, L. Thomson, W. Borland, and N.C. Thomson. 2003. Cigarette smoking impairs the therapeutic response to oral corticosteroids in chronic asthma. Am. J. Respir. Crit. Care Med. 168:1265–1266.
- Ito, K., T. Hanazawa, K. Tomita, P.J. Barnes, and I.M. Adcock. 2004. Oxidative stress reduces histone deacetylase (HDAC)2 activity and enhances IL-8 gene expression: role of tyrosine nitration. Biochem. Biophys. Res. Commun. 315:240–245.
- Ito, K., G. Caramori, A. Papi, P. Casolari, A. Ciaccia, L.M. Fabbri, P.J. Barnes, and I.M. Adcock. 2002. Histone deacetylase expression and activity in COPD. Am. J. Respir. Crit. Care Med. 168:B5 (Abstr).
- Viatour, P., S. Legrand-Poels, C. Van Lint, M. Warnier, M.P. Merville, J. Gielen, J. Piette, V. Bours, and A. Chariot. 2003. Cytoplasmic IkappaBalpha increases NF-kappaB-independent transcription through binding to histone deacetylase (HDAC) 1 and HDAC3. J. Biol. Chem. 278:46541–46548.
- Zhong, H., M.J. May, E. Jimi, and S. Ghosh. 2002. The phosphorylation status of nuclear NF-kappa B determines its association with CBP/p300 or HDAC-1. Mol. Cell. 9:625–636.
Source: PubMed